PolyPid Ltd.

( )
PYPD PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.24%144.240.7%$895.13m
PFEPfizer Inc. 0.03%37.080.9%$764.19m
MRKMerck & Co., Inc. -0.01%78.070.7%$625.56m
BMYBristol-Myers Squibb Co. -0.18%59.871.0%$620.83m
ABBVAbbVie, Inc. 0.40%83.201.9%$594.00m
LLYEli Lilly & Co. 0.37%141.801.1%$485.46m
AZNAstraZeneca Plc 0.56%51.861.2%$203.32m
NVSNovartis AG -0.30%83.890.2%$141.60m
GSKGlaxoSmithKline Plc -0.28%35.250.2%$138.50m
NVONovo Nordisk A/S 0.00%70.850.1%$69.94m
RPRXRoyalty Pharma Plc 0.77%39.300.2%$64.14m
RGENRepligen Corp. 0.00%171.767.1%$62.43m
SNYSanofi -0.53%48.910.2%$49.71m
AMAGAMAG Pharmaceuticals, Inc. 0.00%13.6322.1%$45.03m
OPKOPKO Health, Inc. 1.08%4.2211.2%$40.95m

Company Profile

PolyPid Ltd. is a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes. The company was founded by Noam Emanuel in 2008 and is headquartered in Petach Tikva, Israel.